Oral mucositis (OM) is an adverse effect of cancer treatment, including chemotherapy and radiation therapy. About 90% of head and neck cancer patients receiving chemo- and radiotherapies and 60 to 85% of cancer patients receiving hematopoietic stem cell transplantation develop OM. Its characteristic features include erythema, ulceration, and atrophy of the oral mucosa. In addition, OM leads to alterations in taste, dysphagia, secondary infections, and weight loss.
However, OM can be managed by anti-inflammatory agents, antimicrobials, natural medications, laser therapy, cryotherapy, and by maintaining oral hygiene. Join renowned oral medicine and radiology specialist Dr. Priyanka Sakhavalkar to gain detailed insights into the management of oral mucositis in our exclusive webinar on 2 nd January at 3:00 PM IST . Session highlights Oral mucositis as a sequela of cancer therapy Oral…
